HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

B Nowlan Selected Research

Preleukemia

10/2015Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


B Nowlan Research Topics

Disease

1Myeloid Leukemia (Leukemia, Myelocytic)
10/2015
1Lymphoma (Lymphomas)
10/2015
1Preleukemia
10/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2015
1Hematologic Neoplasms (Hematological Malignancy)
06/2015

Drug/Important Bio-Agent (IBA)

1Messenger RNA (mRNA)IBA
10/2015
1Complementary DNA (cDNA)IBA
10/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2015

Therapy/Procedure

2Transplantation (Transplant Recipients)
10/2015 - 06/2015